Psychedelic advocate optimistic on ecstasy’s future

Rick Doblin spent more than 30 years trying to turn the psychedelic drug MDMA into an accepted medical treatment for post-traumatic stress disorder. Last month, the Food and Drug Administration finally ruled: Denied.